8-K: Richtech Robotics to Restate Past Financials
Non-Reliance on Financial Statements
Richtech Robotics Inc. announced that its previously issued financial statements for fiscal years 2024 and 2025, and several interim periods, should no longer be relied upon due to accounting errors.
Summary
- The Audit Committee concluded that financial statements for fiscal years ended September 30, 2025, and September 30, 2024, and interim periods ended December 31, 2024, March 31, 2025, June 30, 2025, and December 31, 2025, require restatement.
- Errors relate to accounting for warrants issued during fiscal years ended September 2025 and 2024, a Standby Equity Purchase Agreement (SEPA) dated February 15, 2024, and restricted stock awards issued in December 2025.
- The company expects the restatement to primarily involve non-cash accounting adjustments and does not currently anticipate an impact on its cash position, operating cash flows, or business operations.
- An additional material weakness relating to financial instruments is expected to be reported, and a previously reported material weakness as of September 30, 2025, which was stated as remediated, has not been remediated.
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a significantly negative development due to the non-reliance on past financials, multiple accounting errors, and persistent material weaknesses in internal controls, which severely undermine investor confidence despite the expected non-cash nature of adjustments.
Negatives
- Previously issued audited financial statements for fiscal years ended September 30, 2025, and September 30, 2024, and unaudited interim financial statements for several periods, cannot be relied upon.
- Errors in accounting for warrants issued during fiscal years ended September 2025 and 2024.
- Errors in accounting for the Standby Equity Purchase Agreement (SEPA) dated February 15, 2024.
- Errors in accounting for restricted stock awards issued in December 2025.
- Earnings and press releases related to these periods should no longer be relied upon.
- The report of the prior Independent Registered Public Accounting Firm for fiscal years 2024 and 2025 should not be relied upon.
- Expectation to report an additional material weakness relating to financial instruments.
- A material weakness in internal control over financial reporting as of September 30, 2025, previously reported as remediated, has not been remediated.
Risks
- The identification of errors is preliminary, unaudited, and subject to change as procedures are completed.
- Ongoing evaluation of potential errors in other accounting areas, which, if found, could lead to material adjustments beyond those currently identified.
- The existence of material weaknesses in internal control over financial reporting, including an additional expected weakness related to financial instruments, indicates a heightened risk of future accounting errors.
Future Outlook
The company expects the restatement to primarily involve non-cash accounting adjustments and does not currently anticipate it will affect its cash position, operating cash flows, or business operations. However, it is evaluating potential errors in other areas, which, if found, could lead to material adjustments. The company also expects to report an an additional material weakness related to financial instruments.
Management Comments
- "The Company expects that the Restated Financial Statements will reflect (1) the correct accounting for the warrants issued during fiscal years ended September 30, 2025 and 2024, for the SEPA and for the restricted stock awards issued in December 2025 and (2) other immaterial adjustments."
- "Based on its current preliminary analysis, the Company expects that the Restatement will primarily involve non-cash accounting adjustments and does not currently expect the Restatement to affect its cash position, operating cash flows or business operations."
Industry Context
StockSavvy.ai notes that financial restatements, particularly those involving material weaknesses in internal controls and complex financial instruments like warrants and equity purchase agreements, are significant events that can erode investor confidence. Such issues often highlight broader challenges in financial reporting accuracy and corporate governance within the robotics or emerging technology sectors, where rapid growth can sometimes outpace robust internal controls.
Comparison to Industry Standards
- The need for a restatement due to errors in accounting for warrants, a Standby Equity Purchase Agreement (SEPA), and restricted stock awards indicates a significant deviation from standard accounting practices and internal control effectiveness expected of publicly traded companies, especially those listed on Nasdaq.
- The disclosure of an additional material weakness in financial instruments and the non-remediation of a previously identified material weakness suggest a systemic issue in financial reporting, contrasting sharply with the robust internal control environments typically maintained by industry leaders like Boston Dynamics (robotics) or NVIDIA (AI/tech, often involved in complex equity structures).
- While specific comparable companies with identical restatement issues are not named in the filing, any company undergoing such a restatement would generally be viewed as having weaker financial governance compared to peers that consistently produce reliable financial reports.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Internal Control Weakness | The company expects to report an additional material weakness relating to financial instruments. A previously reported material weakness as of September 30, 2025, which was stated as remediated, has not been remediated. | NA | Indicates significant deficiencies in the company's financial reporting processes and oversight, increasing the risk of future errors and potentially impacting investor confidence and regulatory compliance. |
Stakeholder Impact
- Shareholders will face uncertainty regarding the accuracy of past financial performance, potentially leading to decreased stock price and reduced confidence.
- Investors will need to re-evaluate investment decisions based on restated financials and concerns about internal controls.
- Regulatory Authorities will scrutinize the restatement process and the company's remediation efforts for internal control weaknesses.
Next Steps
- Restate audited financial statements for fiscal years ended September 30, 2025, and 2024, in an amended Annual Report on Form 10-K/A.
- Include restated unaudited financial information for quarters ended December 31, 2024, March 31, 2025, and June 30, 2025, within the Comprehensive Amended Form 10-K.
- File an amended Quarterly Report Form 10-Q/A to restate financial statements for the quarter ended December 31, 2025.
- Continue evaluating potential errors in other accounting areas.
- Address conclusions regarding internal control over financial reporting in the Comprehensive Amended Form 10-K.
Key Dates
| Date | Description |
|---|---|
| 2024-02-15 | Date of the Standby Equity Purchase Agreement (SEPA) with YA II PN, Ltd. |
| 2024-09-30 | End of fiscal year for which audited financial statements require restatement. |
| 2024-12-31 | End of interim period for which unaudited financial statements require restatement. |
| 2025-03-31 | End of interim period for which unaudited financial statements require restatement. |
| 2025-06-30 | End of interim period for which unaudited financial statements require restatement. |
| 2025-09-30 | End of fiscal year for which audited financial statements require restatement; also the date of a previously reported material weakness in internal control over financial reporting. |
| 2025-12-01 | Month in which certain restricted stock awards were issued, requiring accounting correction. |
| 2025-12-31 | End of interim period for which unaudited financial statements require restatement. |
| 2026-03-19 | Date of Current Report on Form 8-K disclosing the appointment of CBIZ CPAs P.C. as the new independent registered public accounting firm. |
| 2026-03-31 | End of quarter during which the new independent registered public accounting firm, CBIZ CPAs P.C., discovered the need for restatement. |
| 2026-06-09 | Date the Audit Committee concluded that previously issued financial statements should not be relied upon and require restatement. |
| 2026-06-11 | Date the Form 8-K was signed by the Chief Executive Officer and Director. |
| 2026-09-30 | End of fiscal year for which CBIZ CPAs P.C. has been appointed to audit the company's financial statements. |
Recommendation
sellThe non-reliance on multiple periods of financial statements, coupled with the disclosure of persistent and new material weaknesses in internal controls, signals significant governance and reporting issues. While the company states the adjustments are expected to be non-cash, the fundamental lack of reliable financial information and control deficiencies create substantial uncertainty and risk for investors, warranting a sell recommendation until these issues are fully resolved and confidence in financial reporting is restored.
Keywords
Richtech Robotics, RR, SEC Filing, 8-K, Financial Restatement, Accounting Errors, Warrants, SEPA, Restricted Stock Awards, Material Weakness, Internal Controls, Audit Committee, CBIZ CPAs
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.